搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Shewanella sp. Holliday junction ATP-dependent DNA helicase RuvA (ruvA) CSB-YP605055SAAO
CSB-EP605055SAAO
CSB-BP605055SAAO
CSB-MP605055SAAO
CSB-EP605055SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. 50S ribosomal protein L35 (rpmI) CSB-YP605056SAAO
CSB-EP605056SAAO
CSB-BP605056SAAO
CSB-MP605056SAAO
CSB-EP605056SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. tRNA 2-thiocytidine biosynthesis protein TtcA (ttcA) CSB-YP605057
CSB-EP605057
CSB-BP605057
CSB-MP605057
CSB-EP605057-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. 7-cyano-7-deazaguanine synthase (queC) CSB-YP605058SAAO
CSB-EP605058SAAO
CSB-BP605058SAAO
CSB-MP605058SAAO
CSB-EP605058SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Electron transport complex protein RnfE (rnfE), partial CSB-YP605059SAAO1
CSB-EP605059SAAO1
CSB-BP605059SAAO1
CSB-MP605059SAAO1
CSB-EP605059SAAO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Co-chaperone protein hscB homolog (hscB) CSB-YP605060SAAO
CSB-EP605060SAAO
CSB-BP605060SAAO
CSB-MP605060SAAO
CSB-EP605060SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Ribosomal RNA small subunit methyltransferase F (rsmF) CSB-YP605061SAAO
CSB-EP605061SAAO
CSB-BP605061SAAO
CSB-MP605061SAAO
CSB-EP605061SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Translation initiation factor IF-1 (infA) CSB-YP605062SAAO
CSB-EP605062SAAO
CSB-BP605062SAAO
CSB-MP605062SAAO
CSB-EP605062SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Putative phosphotransferase Shewmr7_1666 (Shewmr7_1666) CSB-YP605063SAAO
CSB-EP605063SAAO
CSB-BP605063SAAO
CSB-MP605063SAAO
CSB-EP605063SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Cell division protein ZipA homolog (zipA), partial CSB-YP605064SAAO
CSB-EP605064SAAO
CSB-BP605064SAAO
CSB-MP605064SAAO
CSB-EP605064SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Tryptophan synthase beta chain (trpB) CSB-YP605065SAAO
CSB-EP605065SAAO
CSB-BP605065SAAO
CSB-MP605065SAAO
CSB-EP605065SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Glycosyl hydrolase family 109 protein 1 (Shewmr7_1440) CSB-YP605066SAAO
CSB-EP605066SAAO
CSB-BP605066SAAO
CSB-MP605066SAAO
CSB-EP605066SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Flagellar L-ring protein (flgH) CSB-YP605067SAAO
CSB-EP605067SAAO
CSB-BP605067SAAO
CSB-MP605067SAAO
CSB-EP605067SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (ispG) CSB-YP605068SAAO
CSB-EP605068SAAO
CSB-BP605068SAAO
CSB-MP605068SAAO
CSB-EP605068SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Protein RecA (recA) CSB-YP605069SAAO
CSB-EP605069SAAO
CSB-BP605069SAAO
CSB-MP605069SAAO
CSB-EP605069SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Ribosomal RNA large subunit methyltransferase E (rlmE) CSB-YP605070SAAO
CSB-EP605070SAAO
CSB-BP605070SAAO
CSB-MP605070SAAO
CSB-EP605070SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Ribosomal RNA large subunit methyltransferase H (rlmH) CSB-YP605071SAAO
CSB-EP605071SAAO
CSB-BP605071SAAO
CSB-MP605071SAAO
CSB-EP605071SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. DNA polymerase IV (dinB) CSB-YP605072SAAO
CSB-EP605072SAAO
CSB-BP605072SAAO
CSB-MP605072SAAO
CSB-EP605072SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. 2-dehydro-3-deoxyphosphooctonate aldolase (kdsA) CSB-YP605073SAAO
CSB-EP605073SAAO
CSB-BP605073SAAO
CSB-MP605073SAAO
CSB-EP605073SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. NAD-dependent malic enzyme (maeA), partial CSB-YP605074SAAO
CSB-EP605074SAAO
CSB-BP605074SAAO
CSB-MP605074SAAO
CSB-EP605074SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>